Skip to main content
Log in

New thermoreversible liquid embolic agent for embolotherapy: technical report

  • Interventional Neuroradiology
  • Published:
Neuroradiology Aims and scope Submit manuscript

Abstract

Introduction

To evaluate potential feasibility of new liquid embolic agent, thermoreversible gelation polymer (TGP), for embolotherapy.

Methods

TGP is a liquid polymer that was originally developed as a cell culture medium for tissue engineering. TGP becomes liquid at temperatures lower than the sol–gel transition temperature (TT) and becomes a gel at temperatures higher than the TT. The TT can be adjusted from 10°C to 40°C, allowing gelation at body temperature without solvent. The renal arteries in six swine were embolized with TGP. Angiographic evaluations were obtained 0, 3 h, and 14 days after embolization. The animals were sacrificed at day 14 after angiogram.

Results

All renal arteries were successfully embolized with TGP using cooling catheter. No acute and chronic clinical complication was observed. Follow-up angiogram demonstrated complete or near complete occlusion of renal arteries. No untoward inflammatory response was observed in acute and chronic specimen.

Conclusion

This embolic material has potential feasibility to be used in the treatment of cerebral arteriovenous malformations, aneurysms, or hyper vascular tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Yoshioka H, Mori Y, Shimizu M (2003) Separation and recovery of DNA fragments by electrophoresis through a thermoreversible hydrogel composed of poly(ethylene oxide) and poly(propylene oxide). Anal Biochem 323:218–223. doi:10.1016/j.ab.2003.09.010

    Article  PubMed  CAS  Google Scholar 

  2. Brothers MF, Kaufmann JC, Fox AJ, Deveikis JP (1989) n-Butyl 2-cyanoacrylate—substitute for IBCA in interventional neuroradiology: histopathologic and polymerization time studies. AJNR Am J Neuroradiol 10:777–786

    PubMed  CAS  Google Scholar 

  3. Murayama Y, Vinuela F, Ulhoa A, Akiba Y, Duckwiler GR, Gobin YP, Vinters HV, Greff RJ (1998) Nonadhesive liquid embolic agent for cerebral arteriovenous malformations: preliminary histopathological studies in swine rete mirabile. Neurosurgery 43:1164–1175. doi:10.1097/00006123-199811000-00081

    Article  PubMed  CAS  Google Scholar 

  4. Chaloupka JC, Vinuela F, Vinters HV, Robert J (1994) Technical feasibility and histopathologic studies of ethylene vinyl copolymer (EVAL) using a swine endovascular embolization model. AJNR Am J Neuroradiol 15:1107–1115

    PubMed  CAS  Google Scholar 

  5. Arai T, Joki T, Akiyama M, Agawa M, Mori Y, Yoshioka H, Abe T (2006) Novel drug delivery system using thermoreversible gelation polymer for malignant glioma. J Neurooncol 1:9–15. doi:10.1007/s11060-005-9001-4

    Article  Google Scholar 

Download references

Conflict of interest statement

We declare that we have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiroyuki Takao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takao, H., Murayama, Y., Ebara, M. et al. New thermoreversible liquid embolic agent for embolotherapy: technical report. Neuroradiology 51, 95–98 (2009). https://doi.org/10.1007/s00234-008-0469-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00234-008-0469-4

Keywords

Navigation